Key Insights

Highlights

Treatment Research

3 treatments under study, led by Lipidomic Analyses

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Enrolling By Invitation1
Not Yet Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT02948361Not ApplicableEnrolling By InvitationPrimary

Clinical PRoduct DevelOpment StudyinG the QT Ultrasound® BReast ScannEr With Volunteer SubjectS

NCT06944548Phase 2Not Yet Recruiting

Evaluation of the Effect of Adapted Physical Activity on the Modification of Lipid Metabolism During Chemotherapy for Metastatic COLorectal Cancer

Showing all 2 trials

Research Network

Common Treatments

  • Lipidomic Analyses1
  • Adapted Physical Activity Program1
  • Qt Ultrasound Breast Scan1

Active Sponsors

  • QT Ultrasound LLC1
  • Institut National de la Santé Et de la Recherche Médicale, France1
  • Centre Georges Francois Leclerc1

Top Investigators

Related Conditions

  • Metastatic Colorectal Cancer Crc1

Activity Timeline